₨ 155,000
Tucaxen 150 mg (tucatinib) is an oral targeted therapy medication used in combination with other drugs to treat specific types of advanced cancer. It is manufactured by Everest Pharmaceuticals Ltd.
Key Information
- Active Ingredient: Tucatinib INN 150 mg
- Manufacturer: Everest Pharmaceuticals Ltd.
- Form: Oral tablets
- Packaging: 30 tablets per box
Uses
Tucatinib is primarily used in combination therapy for:
- HER2-positive metastatic breast cancer that has spread to other parts of the body, including the brain, or cannot be surgically removed. It is for patients who have previously received at least one other anti-HER2 treatment.
- RAS wild-type, HER2-positive advanced colorectal cancer that has progressed after prior chemotherapy treatments.
Tucatinib works by blocking the HER2 protein, which helps slow the growth and spread of cancer cells.Common Side Effects
Common side effects when used in combination with other therapies include:
- Diarrhea (can be severe)
- Rash or hand-foot syndrome (redness, pain, or blisters on hands/feet)
- Nausea and vomiting
- Fatigue (tiredness)
- Increased liver enzymes (monitored by blood tests)
- Mouth sores (stomatitis)
- Decreased appetite
- Headache
- Anemia (low red blood cell count)
Disclaimer: This information is for informational purposes only and does not constitute medical advice. Consult a healthcare professional for diagnosis and treatment of medical conditions.
₨ 10,000
